Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 May 2003 : Original article  

Peroxynitrite-PARP-1 pathway in traumatic brain injury in rats

V. Besson, N. Croci, R. Boulu, M. Plotkine, C. Marchand-Verrecchia

Med Sci Monit 2003; 9(1): 3-0 :: ID: 14988


Background:Nitric oxide and free radicals contribute to injury elicited by traumatic brain injury (TBI) [1,2]. Peroxynitrite, resulting from the combination of nitric oxide and superoxide anion triggers DNA strand breakage, leading to the activation of poly(ADP-ribose)polymerase-1 (PARP-1) [3]. As excessive activation of this enzyme induces cell death, we examine the implication of peroxynitrite-PARP-1 pathway in the post-traumatic outcomes of focal TBI caused by fluid percussion on rats [4]. Material/Methods:In a first experiment, animals were killed 30 min, 2, 4, 6, 24, 48 and 72h after TBI for immunohistochemistry of a) 3-nitrotyrosine as a footprint of peroxynitrite production and b) poly(ADP-ribose) as a marker of PARP-1 activation. In a second experiment, the effect of 3-aminobenzamide (3-AB), a widely used PARP inhibitor, was investigated on the neurological deficit, the cerebral lesion and the activation of PARP-1. Rats were given 3-AB (10 and 30 mg/kg, i.p.) or its vehicle 30 min before, and 24, 48 and 72h after TBI. Results: Immunohistochemistry showed that 3-nitrotyrosine and poly(ADP-ribose) were present as early as 30 min post-injury, and persisted for 72h. Treatment with 3-AB significantly decreased the neurological deficit, the cerebral lesion and the poly(ADP-ribose) staining induced by TBI. Conclusions: The present study indicates that TBI induces peroxynitrite production associated with PARP-1 activation. Treatment with 3-AB, a PARP inhibitor, decreases the neurological deficit, the cerebral lesion and the PARP-1 activation caused by TBI. Thus, PARP-1 is involved in the pathogenesis of TBI and may be a promising therapeutic target for the treatment of brain trauma.References: 1.Mésenge C et al: J Neurotrauma, 1996; 13: 209-214 2.Mésenge C et al: J Pineal Res, 1998; 25: 41-46 3.Virág L, Szabó C: Pharmacol Rev, 2002; 54: 375-429 4.Toulmond S et al: Brain Res, 1993; 620: 24-31

Keywords: 3-nitrotyrosine, 3-aminobenzamide, neuroprotection, poly(ADP-ribose)polymerase-1, peroxynitrite, traumatic brain injury

Add Comment 0 Comments

323 0


01 June 2023 : Editorial  

Editorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness

Dinah V. Parums
Science Editor, Medical Science Monitor, International Scientific Information, Inc., Melville, NY, USA

DOI: 10.12659/MSM.941209

Med Sci Monit 2023; 29:e941209


In Press

01 Jun 2023 : Clinical Research  

Root Canal Numbers and Configurations in 1080 Permanent Canine Teeth in 270 Saudi Subjects Using Cone-Beam ...

Med Sci Monit In Press; DOI: 10.12659/MSM.940472  

01 Jun 2023 : Clinical Research  

Internal Orifice Alloy Closure: A New Procedure for Treatment of Perianal Fistulizing Crohn’s Disease

Med Sci Monit In Press; DOI: 10.12659/MSM.940873  

01 Jun 2023 : Clinical Research  

Effectiveness of Needle Aspiration versus Surgical Excision for Symptomatic Synovial Cysts of the Hip: A Si...

Med Sci Monit In Press; DOI: 10.12659/MSM.940187  

01 Jun 2023 : Clinical Research  

Influence of Insulin Resistance on Diabetes Nephropathy

Med Sci Monit In Press; DOI: 10.12659/MSM.939482  

Most Viewed Current Articles

13 Nov 2021 : Clinical Research  

Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...

DOI :10.12659/MSM.932788

Med Sci Monit 2021; 27:e932788


30 Dec 2021 : Clinical Research  

Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...

DOI :10.12659/MSM.935379

Med Sci Monit 2021; 27:e935379

08 Mar 2022 : Review article  

A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...

DOI :10.12659/MSM.936292

Med Sci Monit 2022; 28:e936292

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750